Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
81 Cards in this Set
- Front
- Back
Supresses both insulin and glucagon release
|
Somatostatin: Delta cells
|
|
Histological features of Beta cells. Alpha cells?
|
Membrane bound granules with a dense rectangular core and halo
Round with closely applied membranes and a dense center |
|
Three criteria for establishing diabetes:
|
1. Random glucose above 200 w/ symptoms
2. fasting BG level greater than 126 3. Abnormal OGTT with glucose greater than 200, 2 hrs after. |
|
Most important anabolic hormone known
|
insulin
|
|
Secreted by enterochromafinn cells
|
Serotonin
|
|
Prediabetic levels
|
Fasting: 100-126
OGTT: 140-200 |
|
Automimmune disease characterized by pancreatic B-cell destruction and absolute insulin deficiency
|
Type I diabetes
|
|
A combination of peripheral resistance and an inadequate secretory response by B-cells.
|
Type II diabetes
|
|
Facilitates hepatic gluconeogenesis and glycogenolysis
|
Glucagon
|
|
Primary determinant of fasting glucose levels
|
Hepatic glucose output
|
|
Major insulin receptor site for post-prandial glucose uptake and utilization.
|
Skeletal muscle
|
|
Serves as a surrogate for B cell function, decreasing with loss of B-cell mass in type I diabetes
|
C-peptide
|
|
Most important stimulus for insulin synthesis and release
|
glucose
|
|
Glucose receptor on pancreatic B-cells
|
Glut-2
|
|
Binding site for oral hypoglycemic agents such as sulfonylureas
|
SUR-1
|
|
How does binding of glucose to the Glut 2 cell receptor cause insulin release?
|
Binding of Glut-2 receptor causes its uptake into the cell, where it is metabolized through glycolysis. This generates ATP, which shuts down the Na/K ATP-sensitive channel, and the membrane is depolarized. Ca influx stimulates release of insulin
|
|
Insulin increases the rate of glucose uptake mainly where? What is it stored as?
|
striated muscle: stored as glycogen
adipose tissue (small amount): lipid |
|
Glucose uptake in the brain
|
insulin independant
|
|
Insulin receptor
|
Tetrameric protein composed of two alpha and two beta subunits
|
|
Which inuslin receptor subunit has tyrosine kinase activity? Is this intra or extra-cellular. Action?
|
B subunit: this is intracellular
Autophosphorylation of the IRS proteins, which activate PI3-Kinase and MAP kinase |
|
Insulin binding subunit. Intra or extracellular
|
Alpha subunit: transcellular
|
|
Insulin signaling facilitates the synthesis and transportation of vesicles containing what glucose transporter? Via what enzymes?
|
GLUT-4: PI-3 Kinase activates AKT (protein kinase B), which mediates GLUT-4 synthesis and transport.
|
|
Type I pathogenesis
|
Autoimmune disease in which islet destruction is caused primarily by immune effector cells reacting against endogenous B-cell antigens
|
|
Genetic haplotype consistent with diabetes
|
HLA-DR3 or HLA-DR4
|
|
Major environmental factor leading to Type-I diabetes
|
Viral infections:
1. Bystander damage: viral infection induces islet injury and inflammation leading to B-cell activation and autoreactive T cell destruction. 2. Mimicry: Virus mimics B-cell antigens and immune response cross reacts with self-tissue 3. Viral deja vu: Predisposing virus is reactivated in the tissue with re-exposure, leading to an immune response. |
|
When do classical clinical manifestations present?
|
Occur late in the course, when 90% of islet cells are destroyed.
|
|
Fundamental immune abnormality in type I diabetes. Where does initial activation of these cells occur?
|
Failure of self-tolerance in T cells
Peripancreatic lymph nodes, in response to antigens released from damaged islets |
|
Largest contributor to the pathogenesis of insulin resistance
|
Decreased insulin sensitivity in hepatocytes
|
|
Relationship of NEFA's and insulin sensitivity. Mechanism of decreased insulin sensitivity?
|
Inverse: NEFA's cause accumulation of DAG and Ceramide, which activate serine/threonine kinases, which phophorylate the insulin receptor and IRS proteins at serine residues, thereby inactivating them.
|
|
Phosphorylation attenuates insulin signaling
|
Serine residues; tyrosine residues activates insulin signaling.
|
|
Insulin inhibits what enzyme that is key for gluconeogenesis?
|
PEPCK- the first enzyme
|
|
Why is central adipose deposition associated with more deleterious effects than peripheral fat deposition
|
Its more lipolytic, leading to increased amounts of plasma fatty acids.
|
|
Anti-hyperglycemic adipokines. Mechanism of action
|
Leptin and adiponectin:
Increase insulin sensitivity by activating AMPK, an enzyme that promotes fatty acid oxidation in liver and skeletal muscle |
|
Levels of what are reduced in obesity
|
adiponectin
|
|
Target of metformin
|
AMPK, which increases fatty acid oxidation in skeletal muscle and liver
|
|
How does inflammation affect insulin sensitivity?
|
Decreases it by activating TNF, IL-1, IL-6, which induce cellular stress, and activate insulin counter-regulatory hormones.
|
|
Characteristic finding of long-standing type II diabetics
|
amyloid replacement of islets
|
|
What other factor must be present besides insulin resistance, to lead to over diabetes?
|
Beta-cell failure. Without this, many insulin resistant obese people will continue to secrete elevated levels of insulin, making up for receptor dysfunction.
|
|
PPAR-Gamma is a receptor and transcription factor expressed where? Function? What line of medications act as agonists?
|
Adipocytes: Promotes secretion of adiponectin and shifts deposition of NEFA's away from skeletal and muscle tissue and towards adipose tissue.
Thiazolidinediones |
|
Monogenic diabetes. What is its inheritance pattern? What form is most common?
|
Primary defect in Beta-cell function or insulin receptor signaling.
Autosomal dominant with high penetrance. MODY2 with enzyme dysfunction of glucokinase (GCK gene) |
|
Permanent neonatal diabetes
|
Caused by a gain-of-function mutation of the ATPase K channel, leading to membrane hyperpolarization, and hypoinsulinemic diabetes.
|
|
Characteristic finding of genetic defects of insulin receptor or action
|
Hyperpigmentation of skin known as acanthosis nigrans
|
|
Enzyme dysfunction associated with gestational diabetes
|
Glucokinase gene
|
|
The effects of microvascular disease are most profound in what organs?
|
Capillary dysfunction of Retina, Kidney, and peripheral nerves
|
|
Mcarovascular disease causes what
|
Accelerated atherosclerosis
|
|
What is the key mediator of long-term complications of diabetes
|
Persistent hyperglycemia
|
|
HB1ac
|
non-enzymatic glycosylation of glucose to Hb
|
|
AGE cross linking with what protein, decreases large vessel elasticity, and predisposes them to shear stress and endothelial injury
|
Collagen type I
|
|
Decreases endothelial cell adhesion and increases extravasation of fluid from basement membrane
|
AGE induced crosslinking to type IV collagen
|
|
RAGE
|
Receptor that binds AGE's on inflammatory cells, vascular smooth muscle, and enodthelium
|
|
What pathology occurs in the kidneys due to AGE's?
|
AGE-crosslinked matrix in the glomerular capillary basement membrane bind and trap albumin, causing basement membrane thickening
|
|
Deliterious effects of AGE-RAGE signaling
|
1. Release of pro-inflammatory cytokines and growth factors from intimal macrophages
2. Generation of ROS from endothelium 3. Increased procoagulation activity 4. Proliferation of vascular smooth muscle and extracellular matrix |
|
Intracellular synthesis of DAG from glycolytic intermediates activates what enzyme that leads to many pathogenic effects
|
Protein Kinase C
|
|
Neovascularization characterizing diabetic retinopathy is caused by what?
|
Increase in protein Kinase C which increases VEGF
|
|
How does protein kinase C influence a thrombotic state
|
1. Decreased levels of NO and increased levels of endothelin-1
2. Production of profibrogenic TGF-B, leading to an increased deposition of matrix and basement membrane material. 3. Production of PAI-1: Leading to reduced fibrinolysis 4. Pro-inflammatory cytokines |
|
In what tissues is the polyol pathway influential
|
those that do not require insulin for uptake: nerves, lenses, kidneys, blood vessels
|
|
Polyol Pathway
|
Excess glucose is metabolized by aldose reductase to sorbitol and then to fructose. This rxn uses NADPH, which is also needed for glutathione reductase to reduced glutathione. Without glutathione, the cell becomes susceptible to ROS
|
|
Major underlying cause of diabetic neuropathy
|
hyperglycemia
|
|
pancreatic finding in newborns, whose mother has diabetes
|
Increase in the number and size of islets
|
|
Histological findings of the Pancreas in type I diabetes
|
1. reduction in the number and size of islets
2. Leukocytic infiltration (T cells) of the islets |
|
Histological presentation of the pancreas in type II diabetes
|
1. Subtle reduction in islet cell mass
2. Amyloid deposition within islets in type 2 diabetes begins in and around capillaries |
|
Hallmark of diabetic macrovascular disease? Most common cause of death in diabetics?
|
Accelerated atherosclerosis in the aorta and arteries.
Myocardial Infarction |
|
What diabetic pathology is 100x more common than the general population
|
Gangrene of the lower extremities
|
|
What vascular change is seen hypertensive diabetics?
|
Hyaline arteriosclerosis
|
|
Most consistent morphologic feature of diabetes. Despite this, what feature do they still show?
|
Diffuse thickening of the basement membrane. Despite this, they are more leaky to plasma proteins.
|
|
Glomerular sclerosis
|
Spherical nodular lesions of matrix situated in the periphery of the glomerulus. Nodules show features of mesangiolysis with disruption of the mesangial-capillary interface, and resultant capillary microaneurysms. These lesions advance, the nodules enlarge and engulf the capillaries, destroying the glomerular tuft.
|
|
Glomerular sclerosis lesions are accompanied by?
|
Fibrin caps and capsular drops: prominent accumulations of hyaline material in capillary loops or adherent to Bowman's capsule.
|
|
Most cases of kidney failure occur as a result of what pathological change in diabetics
|
nodular glomerulosclerosis
|
|
End result of glomerular arteriosclerosis
|
Ishemia and tubular atrophy of the kidney, with interstitial fibrosis, and decreases in size.
|
|
What feature of hyaline arteriosclerosis in diabetics is different from all other cases
|
It also affects the efferent arterioles
|
|
Form of pyelonephritis that is common in . Why is there increased susceptability?
|
Necrotizing pappillitis: There is reduced neutrophil function (chemotaxis, endothelial adherence, phagocytosis, and microbicidal activity), impaired cytokine production, and vascular compromise
|
|
Honeymoon period
|
In initial 1-2 yrs after over type I diabetes, there may still lie a residual amount of minimal endogenous insulin secretion. thereafter, the insulin supply is exhausted and exogenous supply increases dramatically.
|
|
Presentation of overt type I diabetes
|
It may abrupt and precipitated by a stressful event or infection that increases the requirement for insulin
|
|
Onset is marked by what clinical features
|
PPP
|
|
Glycosuria causes what?
|
Osmotic diuresis and polyuria, this causes polydipsia, and may lead to hyperosmotic coma
|
|
Decompensated Type II diabetics are at increased risk for?
|
Hyperosmolar nonketotic coma
|
|
The catabolism of proteins and fats tends to induce a negative energy balance, resulting in what symptom
|
polyphagia
|
|
Where are ketone bodies produced. What symptom may produce metabolic ketoacidosis?
|
From oxidation of fatty acyl coenzyme A molecules within the hepatic mitochondria
During dehydration |
|
Earliest manifestations of diabetic nephropathy
|
Microalbuminuria
|
|
All patients with microalbuminuria should be screened for?
|
Macrovascular disease
|
|
Fundamental lesion of retinopathy. how is this induced
|
Neovascularization: Induced by hypoxic conditions that overexpress VEGF in the retina
|